• Company
  • Location and Contacts
  • Management
  • Board of Directors
  • Partners
  • Community
  • Careers
• Products
  • RF 300 for in vitro ADME and High Throughput Screening
  • RF 200 for High Throughput Screening
  • Cartridges and Chemistry Products
  • Integrator
• Contract Research
  • Lead Discovery Service
    • Custom Assay Development
    • Primary Screening
    • Secondary Screening
  • In vitro ADME Screening
    • CYP Inhibition
    • Metabolic Stability
• Resources
  • Case Studies
  • Product Literature
  • Journal Articles
  • Presentations
  • Courses
  • Demo Lab
  • FAQs
• News & Events
  • Press Releases
    • Archived Releases
  • In the News
  • Events
  • Blog

• News and Events
• Press Releases
  • Archived Releases
• In the News
• Events
• Blog

Home Page / News and Events / Press Releases ...

Recent Press Releases

BIOCIUS Signs Distributor Agreement with Wako, Making RapidFire Instruments and Contract Research Services Available to Japanese Market

BIOCIUS Completes Strategic Spin-Out from BioTrove

BioTrove RapidFire Business Unit to Become BIOCIUS Life Sciences

BioTrove Installs First European RapidFire® System at Boehringer Ingelheim and Obtains CE Mark for the Instrument

BioTrove Presents Data Using Agilent’s Time-of-Flight MS System at American Society for Mass Spectrometry Conference (ASMS)

BioTrove Launches RapidFire 300 for in vitro ADME Discovery

GlaxoSmithKline Accelerates Research with BioTrove’s RapidFire® Mass Spectrometry System at Two Key U.S. R&D Sites

Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies

BIOCIUS. Faster Answers.

RapidFire® technology is described in patent numbers 6,932,939, 6,812,030 7,100,460, 7,588,725,